Germany's middle-tech trap: 76% of R&D in mid-tier sectors caps growth
Published 1 d ago3 sourcesEvidence: Reported
Argentine developers Osvaldo Amerio and Diego Cheja have created a heart valve with lifetime durability that removes the need for anticoagulation therapy, addressing a long-standing dilemma in cardiology. The invention holds patents in the US and Europe and is progressing toward regulatory approval. If approved, it could significantly alter cardiac care, though clinical validation and market adoption remain uncertain.
Entities
Published 1 d ago3 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 1 d ago3 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 23 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported